{"id":7804,"date":"2026-02-24T06:08:29","date_gmt":"2026-02-24T06:08:29","guid":{"rendered":"https:\/\/pandapeptides.com\/research\/bpc-157-tb-500\/"},"modified":"2026-04-09T14:26:12","modified_gmt":"2026-04-09T21:26:12","slug":"bpc-157-tb-500","status":"publish","type":"page","link":"https:\/\/pandapeptides.com\/es\/research\/bpc-157-tb-500\/","title":{"rendered":"BPC-157 + TB-500 \u2014 Published Research"},"content":{"rendered":"
\n

\u2190 Back to BPC-157 + TB-500 product page<\/a><\/p>\n

Ver reportes de laboratorio<\/a> \u00b7 Calidad y pruebas<\/a> \u00b7 Preguntas frecuentes<\/a><\/p>\n

\n

Biblioteca de investigaci\u00f3n<\/h3>\n

Published research on these compounds \u2014 for educational purposes only<\/p>\n

\nBPC-157 Nitric Oxide System Interactions<\/summary>\n
\n

BPC-157 has been investigated for its interactions with the nitric oxide (NO) system in multiple animal models. In vitro studies demonstrate that BPC-157 modulates NO synthase (NOS) expression and NO release in endothelial cells. The peptide’s effects on the NO pathway have been characterized in both L-NAME (NOS inhibitor) and L-arginine (NOS substrate) co-administration models, suggesting a modulatory rather than unidirectional mechanism on NO signaling.<\/p>\n

Sikiric P et al. “Brain-gut axis and pentadecapeptide BPC 157: Theoretical and practical implications.” Curr Neuropharmacol.<\/em> 2016. PubMed<\/a><\/p>\n<\/div>\n<\/details>\n

\nBPC-157 Tendon Fibroblast and Growth Factor Research<\/summary>\n
\n

In vitro studies using rat Achilles tendon fibroblasts demonstrated that BPC-157 modulates growth hormone receptor (GHR) expression in a time-dependent manner. At concentrations of 1\u2013100 ng\/mL, the peptide altered GHR mRNA levels and downstream signaling through JAK2\/STAT pathways. Separate studies in tendon explant models showed BPC-157 influenced type I collagen expression and tendon fibroblast migration rates.<\/p>\n

Chang CH et al. “Pentadecapeptide BPC 157 enhances the growth hormone receptor expression in tendon fibroblasts.” Molecules.<\/em> 2014. PubMed<\/a><\/p>\n<\/div>\n<\/details>\n

\nThymosin Beta-4 Actin-Binding and Cell Migration<\/summary>\n
\n

Thymosin beta-4 (T\u03b24) is a 43-amino-acid peptide that sequesters G-actin monomers, regulating actin polymerization dynamics. The active domain (residues 17\u201323, LKKTETQ) has been identified as critical for actin binding. TB-500 contains this active sequence. Research in dermal fibroblast and keratinocyte models demonstrated that T\u03b24 modulates cell migration through Rac1\/Cdc42 GTPase signaling and upregulates matrix metalloproteinases involved in extracellular matrix remodeling.<\/p>\n

Malinda KM et al. “Thymosin beta4 accelerates wound healing.” J Invest Dermatol.<\/em> 1999. PubMed<\/a><\/p>\n<\/div>\n<\/details>\n

\nThymosin Beta-4 Angiogenesis Signaling Pathways<\/summary>\n
\n

Research in endothelial cell models has characterized T\u03b24’s role in angiogenesis signaling. Studies using human umbilical vein endothelial cells (HUVECs) showed that T\u03b24 activates the Akt\/eNOS pathway, increasing nitric oxide production and endothelial tube formation. Matrigel plug assays in murine models demonstrated that T\u03b24 administration influenced vascularization parameters. The mechanism involves interaction with PINCH-1 and integrin-linked kinase (ILK) signaling complexes.<\/p>\n

Smart N et al. “Thymosin beta4 induces adult epicardial progenitor mobilization and neovascularization.” Nature.<\/em> 2007. PubMed<\/a><\/p>\n<\/div>\n<\/details>\n<\/div>\n

\n

Disclaimer:<\/strong> All research citations are provided as references to published laboratory literature only. These materials may summarize in vitro and animal-model findings. Products are sold strictly for laboratory research use. No statements on this page are intended as dosing, administration, treatment, or other human-use guidance.<\/p>\n<\/div>\n<\/div>","protected":false},"excerpt":{"rendered":"

\u2190 Back to BPC-157 + TB-500 product page View Lab Reports \u00b7 Quality & Testing \u00b7 FAQ Research Library Published research on these compounds \u2014 for educational purposes only BPC-157 Nitric Oxide System Interactions BPC-157 has been investigated for its interactions with the nitric oxide (NO) system in multiple animal models. In vitro studies demonstrate […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":7787,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-7804","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/pandapeptides.com\/es\/wp-json\/wp\/v2\/pages\/7804","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pandapeptides.com\/es\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/pandapeptides.com\/es\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/pandapeptides.com\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/pandapeptides.com\/es\/wp-json\/wp\/v2\/comments?post=7804"}],"version-history":[{"count":2,"href":"https:\/\/pandapeptides.com\/es\/wp-json\/wp\/v2\/pages\/7804\/revisions"}],"predecessor-version":[{"id":8635,"href":"https:\/\/pandapeptides.com\/es\/wp-json\/wp\/v2\/pages\/7804\/revisions\/8635"}],"up":[{"embeddable":true,"href":"https:\/\/pandapeptides.com\/es\/wp-json\/wp\/v2\/pages\/7787"}],"wp:attachment":[{"href":"https:\/\/pandapeptides.com\/es\/wp-json\/wp\/v2\/media?parent=7804"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}